Hrt Financial LP Fusion Pharmaceuticals Inc. Transaction History

Hrt Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$7.9 - $21.32 $141,496 - $381,862	17,911 New	17,911 $381,000
Q3 2021 Nov 15, 2021	SELL	$7.83 - $9.41 $111,029 - $133,433	-14,180 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$7.97 - $10.66 $113,014 - $151,158	14,180 New	14,180 $114,000
Q4 2020 Feb 16, 2021	SELL	$11.5 - $13.73 $115,782 - $138,233	-10,068 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$11.8 - $17.1 $118,802 - $172,162	10,068 New	10,068 $0

93K

1.4K

Ticker FUSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,390,500
Description
Fusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. The company has developed Targeted Alpha Therapies platform together with its proprietary Fast-Clear linker technology to enable us to connect alpha particle emitting isotopes to various targeting molecules in order ...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.